An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Xerava

Chemical Nameeravacycline
Dosage FormInjection (intravenous; 1 mg/kg, 1.5 mg/kg)
Drug ClassTetracyclines
SystemDigestive
CompanyTetraphase Pharmaceuticals Inc.
Approval Year2018

Indication

  • For treatment of complicated intra-abdominal infections in adults ≥18 years of age.
Last updated on 11/11/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xerava (Eravacycline) Prescribing Information 2018Tetraphase Pharmaceuticals Inc, Watertown, MA
Document TitleYearSource
Novel tetracyclines versus alternative antibiotics for treating acute bacterial infection: A meta-analysis of randomized controlled trials. 2019Antibiotics
The efficacy and safety of eravacycline in the treatment of complicated intra-abdominal infections: A systemic review and meta-analysis of randomized controlled trials. 2019Journal of Clinical Medicine
Multidrug-resistant Acinetobacter baumannii infections: Current evidence on treatment options and the role of pharmacokinetics/pharmacodynamics in dose optimisation. 2019International Journal of Antimicrobial Agents